Related Experiment Video

Updated: Feb 17, 2026

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
08:49

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

9.6K

Tan IIA inhibits H1299 cell viability through the MDM4‑IAP3 signaling pathway

Yukun Zu1, Jianning Wang1, Wei Ping1

  • 1Department of Thoracic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430022, P.R. China.

Molecular Medicine Reports
|December 6, 2017
PubMed

Insights

Tanshinone IIA (Tan IIA) from Salvia miltiorrhiza suppresses cancer cell growth by reducing MDM4 expression. This enhances apoptosis and sensitizes cells to chemotherapy, offering new cancer treatment strategies.

Area of Science:

  • Pharmacology
  • Molecular Biology
  • Oncology

Background:

  • Tanshinone IIA (Tan IIA), derived from Salvia miltiorrhiza (Danshen), exhibits anti-cancer properties by inhibiting proliferation and inducing apoptosis.
  • The precise molecular mechanisms of Tan IIA-induced apoptosis, particularly in p53-deficient cancer cells, require further investigation.

Purpose of the Study:

  • To elucidate the molecular mechanisms behind the anti-cancer effects of Tan IIA in p53-deficient H1299 non-small cell lung cancer cells.
  • To investigate the impact of Tan IIA on murine double minute 4 (MDM4) expression and its downstream effects on apoptosis-related proteins.

Main Methods:

  • H1299 cells were treated with varying concentrations and durations of Tan IIA.
  • MDM4 mRNA and protein levels were assessed using quantitative real-time PCR and Western blotting.
  • Expression of P73α, inhibitor of apoptosis 3 (IAP3), and P73α target genes (BCL2 binding component 3, phorbol-12-myristate-13-acetate-induced protein 1) were analyzed.
  • Synergistic effects of Tan IIA combined with doxorubicin (DOX) were evaluated.

Main Results:

  • Tan IIA significantly downregulated MDM4 expression in a time- and dose-dependent manner by inhibiting MDM4 mRNA synthesis.
  • Tan IIA-induced MDM4 suppression led to increased P73α and decreased IAP3 levels.
  • P73α activation was not observed, as key target genes remained unaffected.
  • Tan IIA-induced downregulation of IAP3 may contribute to apoptosis and reduced H1299 cell viability.
  • Combined treatment with Tan IIA and DOX resulted in increased MDM4 expression and sensitized cells to DOX-induced apoptosis.

Conclusions:

  • Tan IIA exerts anti-cancer effects in p53-deficient H1299 cells, partly through MDM4 downregulation.
  • The Tan IIA-induced modulation of P73α and IAP3 pathways plays a role in its cytotoxic effects.
  • Tan IIA demonstrates potential as a sensitizing agent, enhancing the efficacy of conventional chemotherapy like doxorubicin in p53-deficient and MDM4-overexpressing cancers.

More Related Videos

Identifying Caspases and their Motifs that Cleave Proteins During Influenza A Virus Infection08:16

Identifying Caspases and their Motifs that Cleave Proteins During Influenza A Virus Infection

Published on: July 21, 2022

1.9K
Monitoring eIF4F Assembly by Measuring eIF4E-eIF4G Interaction in Live Cells08:47

Monitoring eIF4F Assembly by Measuring eIF4E-eIF4G Interaction in Live Cells

Published on: May 1, 2020

3.4K

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
13.2K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.4K